Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
HMP.TO 0.01SPGP 1.715ZUQ.TO 1.27NVDA 7.15GL 2.43MRK -3.06IEMG 1.96GEV 34.91
Patheon (PTI.TO)

Patheon (PTI.TO)

0.00
-0.00 (0.00%)
6 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
BUY

Patheon(PTI.TO)

Jul 29, 2005
Should have good support at about $7.50/8.00. It is very important that the stock doesn't go any lower. Keep a very short fuse on the stock and if it starts to go below $7.50 get out.
Photo of Ron MeiselsRon Meisels
No
Unlock Rating
$9.10

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Patheon(PTI.TO)

Jul 26, 2005
Doesn't own. Wanted them to have 1 quarter to digest their big acquisition. Solidly managed company that is able to pull off some very good acquisitions which are always accretive to earnings. Cdn$ strength is always a problem for them, but Cdn/US$ interest rate spreads right now are at a 5 year high which will help if that trend continues.
Photo of Peter HodsonPeter Hodson
Owned
Unlock Rating
$8.75

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Patheon(PTI.TO)

Jul 13, 2005
There's no sign whatsoever that they've got this thing turned around. Very little in the Canadian health care sector that looks good.
Photo of David BurrowsDavid Burrows
No
Unlock Rating
$9.10

Stock price when the opinion was issued

biotechnologypharmaceutical
PAST TOP PICK

Patheon(PTI.TO)

Jun 22, 2005
(A Top Pick Jan 14/05. Down 8.5%.) Still likes.
Photo of Fred SturmFred Sturm
Owned
Unlock Rating
$9.15

Stock price when the opinion was issued

biotechnologypharmaceutical
HOLD

Patheon(PTI.TO)

Jun 08, 2005
A really volatile stock. Had some problems with its European operations. Made a big purchase in Puerto Rico which will be a transforming acquisition. Be prepared to live with the volatility.
Photo of Gavin GrahamGavin Graham
Owned
Unlock Rating
$9.45

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Patheon(PTI.TO)

Jun 06, 2005
Doesn't see the current attraction of this company. Any time a company has had 2/3 quarters in a row of poor earnings, you are into a trend and it is best to stay away until things turn around.
Photo of Norman LevineNorman Levine
No
Unlock Rating
$9.65

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Patheon(PTI.TO)

Jun 06, 2005
In a violent trading range.
Photo of Bill CarriganBill Carrigan
No
Unlock Rating
$9.65

Stock price when the opinion was issued

biotechnologypharmaceutical
WATCH

Patheon(PTI.TO)

May 10, 2005
Likes the company a lot. Has owned it on and off in the past. Recent acquisition is a company changing acquisition. Will probably come back into the stock in the next quarter when he knows the acquisition is going very well.
Photo of Peter HodsonPeter Hodson
No
Unlock Rating
$10.30

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Patheon(PTI.TO)

May 10, 2005
Fell on bad times, made a wonderful acquisition in Puerto Rico which gave it a nice uptick, but has just kind of eased back and is now back into buying territory. At $10.30 it's a terrific Buy.
Photo of David BaskinDavid Baskin
Owned
Unlock Rating
$10.30

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Patheon(PTI.TO)

Apr 06, 2005
Likes this stock. Had too much over capacity and with their acquisition of Mova they have better capacity. Have started to gain a little bit of traction in the outsourcing sector.
Photo of John ZechnerJohn Zechner
Owned
Unlock Rating
$11.23

Stock price when the opinion was issued

biotechnologypharmaceutical
WEAK BUY

Patheon(PTI.TO)

Mar 17, 2005
Went through a lot of problems. A $2 stock on the way to $16 and at that stage a lot of happy people who were getting out which resulted into a sell off. There is a turn around happening with the 200 day moving average falling for the last 1 1/2 years, flattening with the potential to support the next move up towards $15 initially.
Photo of Ron MeiselsRon Meisels
No
Unlock Rating
$11.32

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Patheon(PTI.TO)

Mar 08, 2005
Company has new facility in Purto Rico. Likes it. Will go to $15 in 2005
Photo of David BaskinDavid Baskin
Owned
Unlock Rating
$11.75

Stock price when the opinion was issued

biotechnologypharmaceutical
WEAK BUY

Patheon(PTI.TO)

Feb 25, 2005
Stock had been down quite a ways, but chart had shown some positive signs. From September to January, charts show a possible Head/Shoulders Bottom. It broke out in January. In an uptrend and going up, but has had a good part of its potential target moved. Still some left, but would be less inclined to purchase.
Photo of David ChapmanDavid ChapmanUnlock Rating
$10.84

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Patheon(PTI.TO)

Feb 09, 2005
Has been a volatile stock and this is why it's cheap. Have made some acquisitions. Use caution.
Photo of Gordon Higgins, CA, MBAGordon Higgins, CA, MBA
No
Unlock Rating
$11.00

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Patheon(PTI.TO)

Feb 07, 2005
Not a long term pick, but there is a trading call here. Broke through it's long term declining average. Good volume. A developing story. Could do 30/40% over the next 3/6 months.
Photo of Larry Berman CFA, CMT, CTALarry Berman CFA, CMT, CTA
No
Unlock Rating
$11.11

Stock price when the opinion was issued

biotechnologypharmaceutical
Showing 31 to 45 of 194 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

EPD -0.47$36.78
ET -0.025$19.045
MAIR 0$
RKLB 6.095$108.485
SESG-O 0$
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video

Today's Top Picks

HMP.TO 0.01$9.76
SPGP 1.715$122.105
ZUQ.TO 1.27$108.74
NVDA 7.15$212.34
GL 2.43$169.19

Popular Articles

Latest Sell Signals

PRGO -0.14$10.85
CBRS 0$
HAWK 0$
AVEX 0$
SWMR 0$

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Richard Orrell

Richard Orrell

RN Croft Financial Group

Stockchase Insights

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video